Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids.

MLA

Hartman, Linda, et al. “Development of Prediction Models to Select Older RA Patients with Comorbidities for Treatment with Chronic Low-Dose Glucocorticoids.” Rheumatology, vol. 62, no. 5, May 2023, pp. 1824–33. EBSCOhost, https://doi.org/10.1093/rheumatology/keac547.

APA

Hartman, L., Silva, J. A. P. da, Buttgereit, F., Cutolo, M., Opris-Belinski, D., Szekanecz, Z., Masaryk, P., Voshaar, M. J. H., Heymans, M. W., Lems, W. F., Heijde, D. M. F. M. van der, & Boers, M. (2023). Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids. Rheumatology, 62(5), 1824–1833. https://doi.org/10.1093/rheumatology/keac547

Chicago

Hartman, Linda, José A P da Silva, Frank Buttgereit, Maurizio Cutolo, Daniela Opris-Belinski, Zoltan Szekanecz, Pavol Masaryk, et al. 2023. “Development of Prediction Models to Select Older RA Patients with Comorbidities for Treatment with Chronic Low-Dose Glucocorticoids.” Rheumatology 62 (5): 1824–33. doi:10.1093/rheumatology/keac547.